CHRNA7 Antikörper (PE)
Kurzübersicht für CHRNA7 Antikörper (PE) (ABIN736921)
Target
Alle CHRNA7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- CHRNA7 Polyclonal Antibody, PE Conjugated
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CHRNA7
-
Isotyp
- IgG
-
-
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (AA 52-259) antibody
CHRNA7 Reaktivität: Human IHC, ELISA, FACS Wirt: Maus Monoclonal 7F10G1 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (AA 52-259) antibodyCHRNA7 Reaktivität: Human, Ratte WB, ELISA, FACS Wirt: Maus Monoclonal 7F10F1 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (AA 441-502) antibodyCHRNA7 Reaktivität: Human WB, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (AA 31-42), (Extracellular), (N-Term) antibodyKO Validated CHRNA7 Reaktivität: Ratte WB, IHC, FACS, IF, LCI, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (AA 31-42), (Extracellular), (N-Term) antibodyCHRNA7 Reaktivität: Ratte WB, IHC Wirt: Meerschweinchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (AA 23-230) antibodyCHRNA7 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (N-Term) antibodyCHRNA7 Reaktivität: Human, Ratte, Maus WB, IHC, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (AA 23-230) antibodyCHRNA7 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (AA 31-42), (Extracellular), (N-Term) antibody (FITC)CHRNA7 Reaktivität: Ratte FACS, LCI Wirt: Kaninchen Polyclonal FITC
anti-Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (N-Term) antibodyCHRNA7 Reaktivität: Human, Ratte, Maus, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CHRNA7 (Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7))
-
Andere Bezeichnung
- CHRNA7
-
Hintergrund
-
Synonyms: NACHRA7, CHRNA7-2, Neuronal acetylcholine receptor subunit alpha-7, CHRNA7
Background: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. The channel is blocked by alpha-bungarotoxin.
-
Molekulargewicht
- 55kDa
-
Gen-ID
- 1139
-
UniProt
- P36544
-
Pathways
- Synaptic Membrane
Target
-
